Literature DB >> 2836491

Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils.

J B Sedgwick1, R F Vrtis, M F Gourley, W W Busse.   

Abstract

The role of eosinophils in allergic and hypersensitivity diseases has yet to be fully established and remains limited by techniques to isolate the eosinophil in high purity. Consequently, most studies that evaluate and characterize eosinophil function are conducted with isolates from patients with hypereosinophilia. There is, however, evidence to suggest that isolates from such patients do not represent normal function. Now, with new techniques to isolate and purify eosinophils from normal subjects without eosinophilia, metabolic function of the normal eosinophil can be assessed. To accomplish this, granulocytes from healthy volunteers were separated by continuous density Percoll gradients into populations of purified eosinophils (90.3 +/- 1.9%) and neutrophils (98.2 +/- 0.4%). Superoxide (O2-) generation was measured with a microassay of superoxide dismutase-inhibitable cytochrome c reduction in response to several soluble and particulate agonists. Normal eosinophils generated significantly more O2- in response to either phorbol myristate acetate or calcium ionophore A23187 than their matched neutrophil fractions. In contrast, differences in granulocyte response to zymosan and chemotactic peptide, N-formyl-methionyl-leucyl-phenylalanine, were dependent on the presence of cytochalasin B (CB) in the reaction. N-formyl-methionyl-leucyl-phenylalanine-stimulated eosinophils generated less O2- in the absence of CB but similar amounts in the presence of CB, compared to neutrophils. Activation by zymosan in the presence of 10% autologous serum generated similar amounts of O2- in all the cell populations when CB was present; however, in the absence of CB, neutrophils produced less O2- when they were compared to eosinophils. Therefore, normal eosinophils respond differently to some activators, compared to neutrophils, and these differences may prove significant as the contribution of eosinophils to inflammation becomes established.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836491     DOI: 10.1016/0091-6749(88)90945-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  18 in total

1.  Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release.

Authors:  C I Ezeamuzie; E Philips
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes.

Authors:  J Cortijo; V Villagrasa; R Pons; L Berto; M Martí-Cabrera; M Martinez-Losa; T Domenech; J Beleta; E J Morcillo
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 3.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

Review 4.  Pattern-recognition receptors in human eosinophils.

Authors:  Anne Månsson Kvarnhammar; Lars Olaf Cardell
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

5.  Role of tachykinin NK2-receptor activation in the allergen-induced late asthmatic reaction, airway hyperreactivity and airway inflammatory cell influx in conscious, unrestrained guinea-pigs.

Authors:  M Schuiling; A B Zuidhof; H Meurs; J Zaagsma
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

6.  Surfactant protein-A enhances respiratory syncytial virus clearance in vivo.

Authors:  A M LeVine; J Gwozdz; J Stark; M Bruno; J Whitsett; T Korfhagen
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

7.  Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.

Authors:  P M Silva; A C Alves; M F Serra; A L Pires; J P Silva; E O Barreto; R S Cordeiro; P J Jose; M M Teixeira; V Lagente; M A Martins
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

8.  Role of oxygen intermediates in cytotoxicity: studies in chronic granulomatous disease.

Authors:  R L Roberts; B J Ank; M W Fanger; L Shen; E R Stiehm
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

9.  Superoxide production by human eosinophils can be inhibited in an agonist-selective manner.

Authors:  M K Bach; J R Brashler; E N Petzold; M E Sanders
Journal:  Agents Actions       Date:  1992-01

10.  Early signalling events implicated in leukotriene B4-induced activation of the NADPH oxidase in eosinophils: role of Ca2+, protein kinase C and phospholipases C and D.

Authors:  R S Perkins; M A Lindsay; P J Barnes; M A Giembycz
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.